Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Molecular Characterization of the Major Open Reading Frames (ORFs) and Enhancer Elements From Four Geographically Distinct North American Equine Infectious Anemia Virus (EIAV) Isolates.

Cook SJ, Li G, Zheng Y, Willand ZA, Issel CJ, Cook RF.

J Equine Vet Sci. 2020 Feb;85:102852. doi: 10.1016/j.jevs.2019.102852. Epub 2019 Nov 14.

PMID:
31952638
2.

Validation of an immunoblot assay employing an objective reading system and used as a confirmatory test in equine infectious anaemia surveillance programs.

Scicluna MT, Autorino GL, Cook SJ, Issel CJ, Cook RF, Nardini R.

J Virol Methods. 2019 Apr;266:77-88. doi: 10.1016/j.jviromet.2019.01.012. Epub 2019 Jan 23.

PMID:
30684508
3.

Detection of West Nile Virus and other common equine viruses in three locations from the Leeward Islands, West Indies.

Bolfa P, Jeon I, Loftis A, Leslie T, Marchi S, Sithole F, Beck C, Lecollinet S, Zientara S, Hans A, Issel CJ.

Acta Trop. 2017 Oct;174:24-28. doi: 10.1016/j.actatropica.2017.06.023. Epub 2017 Jun 22.

PMID:
28648789
4.

Equine infectious anemia prevalence in feral donkeys from Northeast Brazil.

Oliveira FG, Cook RF, Naves JHF, Oliveira CHS, Diniz RS, Freitas FJC, Lima JM, Sakamoto SM, Leite RC, Issel CJ, Reis JKP.

Prev Vet Med. 2017 May 1;140:30-37. doi: 10.1016/j.prevetmed.2017.02.015. Epub 2017 Feb 24.

PMID:
28460747
5.

Evaluation of six serological ELISA kits available in Italy as screening tests for equine infectious anaemia surveillance.

Nardini R, Autorino GL, Issel CJ, Cook RF, Ricci I, Frontoso R, Rosone F, Scicluna MT.

BMC Vet Res. 2017 Apr 14;13(1):105. doi: 10.1186/s12917-017-1007-6.

6.

Equine infectious anaemia and mechanical transmission: man and the wee beasties.

Issel CJ, Foil LD.

Rev Sci Tech. 2015 Aug;34(2):513-23. Review.

7.

Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Craigo JK, Ezzelarab C, Cook SJ, Liu C, Horohov D, Issel CJ, Montelaro RC.

PLoS Pathog. 2015 Jan 8;11(1):e1004610. doi: 10.1371/journal.ppat.1004610. eCollection 2015 Jan.

8.

Equine infectious anemia in 2014: live with it or eradicate it?

Issel CJ, Cook RF, Mealey RH, Horohov DW.

Vet Clin North Am Equine Pract. 2014 Dec;30(3):561-77. doi: 10.1016/j.cveq.2014.08.002. Epub 2014 Nov 6. Review.

PMID:
25441114
9.

Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.

Liu C, Cook SJ, Craigo JK, Cook FR, Issel CJ, Montelaro RC, Horohov DW.

Vet Immunol Immunopathol. 2014 Oct 15;161(3-4):161-9. doi: 10.1016/j.vetimm.2014.08.001. Epub 2014 Aug 10.

10.

Equine infectious anemia and equine infectious anemia virus in 2013: a review.

Cook RF, Leroux C, Issel CJ.

Vet Microbiol. 2013 Nov 29;167(1-2):181-204. doi: 10.1016/j.vetmic.2013.09.031. Epub 2013 Oct 12. Review.

PMID:
24183747
11.

Envelope determinants of equine lentiviral vaccine protection.

Craigo JK, Ezzelarab C, Cook SJ, Chong L, Horohov D, Issel CJ, Montelaro RC.

PLoS One. 2013 Jun 13;8(6):e66093. doi: 10.1371/journal.pone.0066093. Print 2013.

12.

Is a diagnostic system based exclusively on agar gel immunodiffusion adequate for controlling the spread of equine infectious anaemia?

Scicluna MT, Issel CJ, Cook FR, Manna G, Cersini A, Rosone F, Frontoso R, Caprioli A, Antognetti V, Autorino GL.

Vet Microbiol. 2013 Jul 26;165(1-2):123-34. doi: 10.1016/j.vetmic.2013.02.027. Epub 2013 Mar 28. Erratum in: Vet Microbiol. 2013 Dec 27;167(3-4):744. Antonetti, Valeria [corrected to Antognetti, Valeria].

PMID:
23618837
13.

Challenges and proposed solutions for more accurate serological diagnosis of equine infectious anaemia.

Issel CJ, Scicluna MT, Cook SJ, Cook RF, Caprioli A, Ricci I, Rosone F, Craigo JK, Montelaro RC, Autorino GL.

Vet Rec. 2013 Feb 23;172(8):210. doi: 10.1136/vr-2012-100735. Epub 2012 Nov 16.

14.

The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies.

Liu C, Cook FR, Cook SJ, Craigo JK, Even DL, Issel CJ, Montelaro RC, Horohov DW.

Vet Immunol Immunopathol. 2012 Aug 15;148(3-4):302-10. doi: 10.1016/j.vetimm.2012.06.018. Epub 2012 Jun 23.

15.

Detection, molecular characterization and phylogenetic analysis of full-length equine infectious anemia (EIAV) gag genes isolated from Shackleford Banks wild horses.

Capomaccio S, Willand ZA, Cook SJ, Issel CJ, Santos EM, Reis JK, Cook RF.

Vet Microbiol. 2012 Jun 15;157(3-4):320-32. doi: 10.1016/j.vetmic.2012.01.015. Epub 2012 Jan 18.

PMID:
22310073
16.

Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.

Craigo JK, Barnes S, Cook SJ, Issel CJ, Montelaro RC.

Vaccine. 2010 Nov 29;28(51):8095-104. doi: 10.1016/j.vaccine.2010.10.003. Epub 2010 Oct 16.

17.

An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.

Craigo JK, Barnes S, Zhang B, Cook SJ, Howe L, Issel CJ, Montelaro RC.

Retrovirology. 2009 Oct 20;6:95. doi: 10.1186/1742-4690-6-95.

18.

Full-length and internally deleted forms of interleukin-7 are present in horse (Equus caballus) lymph node tissue.

Cook RF, Cook SJ, Even DL, Schaffer C, Issel CJ.

Vet Immunol Immunopathol. 2008 Sep 15;125(1-2):126-34. doi: 10.1016/j.vetimm.2008.05.006. Epub 2008 May 14.

PMID:
18573542
19.

Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.

Tagmyer TL, Craigo JK, Cook SJ, Even DL, Issel CJ, Montelaro RC.

J Virol. 2008 Apr;82(8):4052-63. doi: 10.1128/JVI.02028-07. Epub 2008 Jan 30.

20.

Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Craigo JK, Zhang B, Barnes S, Tagmyer TL, Cook SJ, Issel CJ, Montelaro RC.

Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15105-10. Epub 2007 Sep 10.

21.

Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.

Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC.

J Gen Virol. 2007 Apr;88(Pt 4):1324-36.

PMID:
17374779
22.

Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.

Craigo JK, Durkin S, Sturgeon TJ, Tagmyer T, Cook SJ, Issel CJ, Montelaro RC.

Vaccine. 2007 Jan 15;25(5):834-45. Epub 2006 Sep 22.

23.

Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.

Craigo JK, Sturgeon TJ, Cook SJ, Issel CJ, Leroux C, Montelaro RC.

Virology. 2006 Jan 20;344(2):340-53. Epub 2005 Oct 13.

24.

Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.

Cook RF, Cook SJ, Bolin PS, Howe LJ, Zhou W, Montelaro RC, Issel CJ.

Vet Microbiol. 2005 Jun 15;108(1-2):23-37.

PMID:
15885929
25.
26.
27.

Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides.

Cook RF, Cook SJ, Berger SL, Leroux C, Ghabrial NN, Gantz M, Bolin PS, Mousel MR, Montelaro RC, Issel CJ.

Virology. 2003 Sep 1;313(2):588-603.

28.
30.

Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV).

Cook RF, Cook SJ, Li FL, Montelaro RC, Issel CJ.

J Virol Methods. 2002 Aug;105(1):171-9.

PMID:
12176154
31.
32.

Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.

Craigo JK, Leroux C, Howe L, Steckbeck JD, Cook SJ, Issel CJ, Montelaro RC.

J Gen Virol. 2002 Jun;83(Pt 6):1353-1359. doi: 10.1099/0022-1317-83-6-1353.

PMID:
12029150
33.

Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

Leroux C, Craigo JK, Issel CJ, Montelaro RC.

J Virol. 2001 May;75(10):4570-83.

34.
35.

Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Hammond SA, Li F, McKeon BM Sr, Cook SJ, Issel CJ, Montelaro RC.

J Virol. 2000 Jul;74(13):5968-81.

37.
38.

Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.

Lichtenstein DL, Craigo JK, Leroux C, Rushlow KE, Cook RF, Cook SJ, Issel CJ, Montelaro RC.

Virology. 1999 Oct 25;263(2):408-17.

39.
41.
42.

General method for the detection and in vitro expansion of equine cytolytic T lymphocytes.

Hammond SA, Issel CJ, Montelaro RC.

J Immunol Methods. 1998 Apr 1;213(1):73-85.

PMID:
9671126
43.
44.
45.

Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.

Cook RF, Leroux C, Cook SJ, Berger SL, Lichtenstein DL, Ghabrial NN, Montelaro RC, Issel CJ.

J Virol. 1998 Feb;72(2):1383-93.

47.
48.
49.

Antiapoptotic compound to enhance hypothermic liver preservation.

Wu G, Tomei LD, Bathurst IC, Zhang F, Hong CB, Issel CJ, Columbano A, Salley RK, Chien S.

Transplantation. 1997 Mar 27;63(6):803-9.

PMID:
9089218

Supplemental Content

Loading ...
Support Center